Company / Operating Income per Share
AYTU BIOPHARMA, INC Operating Income per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.31
FY2025
5-year range
-$8.85 / -$0.29
FY2021-FY2025
Trend
-354.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -354% YoY in FY2025, a notable deviation from the 9-year average annual change of -353%.
Based on SEC 10-K filings.
-1.31 in FY2025.
Improved from $-8.85 to $-1.31 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 354.4% year-over-year.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.31 | -354.4% |
| FY2024 | -$0.29 | +96.7% |
| FY2023 | -$8.85 | -121.3% |
| FY2022 | -$4.00 | +14.5% |
| FY2021 | -$4.68 | -288.3% |
| FY2020 | -$1.20 | +99.7% |
| FY2018 | -$477.65 | -344.1% |
| FY2017 | -$107.57 | -488.9% |
| FY2016 | -$18.26 | -1790.9% |
| FY2015 | -$0.97 | -763.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026